Showing results (81-90 of 189) with videos related to
Sort By:
Pageof 19
Experientia|April 15, 1987
Inactivation of sarin and soman by cyclodextrins in vitroB Désiré, S Saint-AndréThe American Journal of Gastroenterology|March 31, 2001
Self-reported effectiveness and physician consultation rate in users of over-the-counter histamine-2 receptor antagonistsM J Shaw, A M Fendrick, R L Kane, et al.Effective Clinical Practice : ECP|November 1, 2001
Cardiologists performing peripheral angioplasties: impact on utilizationD A Axelrod, A M Fendrick, J D Birkmeyer, et al.The American Journal of Gastroenterology|August 19, 2000
A randomized, controlled trial to assess a novel colorectal cancer screening strategy: the conversion strategy--a comparison of sequential sigmoidoscopy and colonoscopy with immediate conversion from sigmoidoscopy to colonoscopy in patients with an abnormal screening sigmoidoscopyM A Stern, A M Fendrick, W M McDonnell, et al.Health Affairs (Project Hope)|February 24, 2001
Pharmaceutical cost growth under capitation: a case studyM Chernew, M E Cowen, D M Kirking, et al.American Journal of Infection Control|April 5, 2001
Research Priorities Project, year 2000: establishing a direction for infection control and hospital epidemiologyP Lynch, M Jackson, S SaintScience (New York, N.Y.)|August 19, 1977
Agriculture and behavioral science: emerging orientationsW S Saint, E W CowardAnnals of Internal Medicine|November 6, 2001
Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysisU Ladabaum, C L Chopra, G Huang, et al.British Journal of Cancer|March 1, 2002
Clinical and economic impact of multiple gated acquisition scan monitoring during anthracycline therapyI Shureiqi, S B Cantor, S M Lippman, et al.Alimentary Pharmacology & Therapeutics|February 17, 2006
Primary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national surveyW D Chey, S Eswaren, C W Howden, et al.Pageof 19